Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-06-01 @ 8:48 AM
Study NCT ID:
NCT06121505
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2023-10-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer
Sponsor:
Sichuan University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IHC-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |